AbbVie Inc. logo

AbbVie Inc.

NYSE:ABBV

Overview | Financials
Company Name AbbVie Inc.
Symbol ABBV
Currency USD
Price 192.94
Market Cap 340,797,639,600
Dividend Yield 3.75%
52-week-range 135.85 - 199.95
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Richard A. Gonzalez
Website https://www.abbvie.com

An error occurred while fetching data.

About AbbVie Inc.

AbbVie Inc. is a global pharmaceutical company focused on discovering, developing, manufacturing, and selling innovative therapies. Their diverse portfolio offers treatments for various medical conditions. Notable products include HUMIRA, used for autoimmune and intestinal Behçet's diseases, and SKYRIZI, for moderate to severe plaque psoriasis in adults. They also offer RINVOQ for

Related Stocks

Eli Lilly and Company logo

Eli Lilly and Company

LLY

904.97 USD

Merck & Co., Inc. logo

Merck & Co., Inc.

MRK

118.64 USD

Pfizer Inc. logo

Pfizer Inc.

PFE

29.75 USD

Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMO

610.12 USD

Abbott Laboratories logo

Abbott Laboratories

ABT

114.88 USD

Danaher Corporation logo

Danaher Corporation

DHR

271.9 USD

Bristol-Myers Squibb Company logo

Bristol-Myers Squibb Company

BMY

49.74 USD

Medtronic plc logo

Medtronic plc

MDT

88.13 USD

Financials

Numbers are in millions USD

Numbers are in millions USD